2017 Measles-Rubella Vaccination Campaign in India

Shrivastava, Saurabh RamBihariLal; Shrivastava, Prateek Saurabh; Ramasamy, Jegadeesh

doi:10.4103/ijpvm.ijpvm_122_17

Cited by 7 publications

(3 citation statements)

References 2 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…She further goes on to state that there is a need to influence people that parents might discuss their vaccination decisions with. [6] This is what was found to be missing in our campaign because IEC efforts were directed only toward parents with children in the age group of 9 months to 15 years.…”

Section: Discussionmentioning

confidence: 96%

Drivers and barriers for measles rubella vaccination campaign: A qualitative study

Krishnendhu

George

2019

J Family Med Prim Care

View full text Add to dashboard Cite

Background: The measles-rubella (MR) vaccination campaign was launched in Kerala on 3 rd October 2017 aiming to eliminate MR by 2020. The drive was carried out in schools, community centers, and medical institutions. The initial phase of the MR campaign met with many controversies that affected its coverage. Objectives: The objectives of the study were to analyze the drivers and barriers for acceptance of MR vaccination in the field area of a primary health center (PHC), which reported a low coverage (62%) during the initial phase of the campaign. Methods: A qualitative study consisting of key informant interviews of parents of vaccinated and unvaccinated children, medical officers of the PHC, Junior Public Health Nurse (JPHN), and Accredited Social Health Activist (ASHA) workers, and the principals of government and private schools where the campaign was conducted was also interviewed. Results: The major barrier to acceptance of MR campaign was the anti-vaccination propaganda in social media. The messages falsely linked fertility issues with the vaccine. The purpose of this campaign was not properly understood by the parents. The campaign was implemented within a short span of time resulting in coordination issues between the stakeholders. However, it was observed that religious affiliations played a major role in reducing coverage. The drivers to acceptance of MR vaccination campaign were the team effort of the healthcare providers who constantly motivated parents to vaccinate their children. Conclusion: Addressing the anti-vaccination propaganda has become the need of the hour. The inclusion of all stakeholders including religious leaders in the planning and implementation of the campaign is essential for its success.

show abstract

Section: Discussionmentioning

confidence: 96%

Drivers and barriers for measles rubella vaccination campaign: A qualitative study

Krishnendhu

George

2019

J Family Med Prim Care

View full text Add to dashboard Cite

show abstract

“…Subsequently, the 11 Member States of the World Health Organization South East Asian Region (WHO-SEAR) committed to eliminate measles and control rubella/congenital rubella syndrome by 20209. Therefore, the Indian government decided to provide measles rubella (MR) vaccine in a campaign mode to all children of age nine months to <15 yr and later replace the measles vaccine with MR in universal immunization programme in 201710. The Indian Academy of Paediatrics supported elimination of not only measles and rubella, but also of the mumps by administering two doses of measles, mumps and rubella (MMR) vaccine11.…”

mentioning

confidence: 99%

Seroprevalence of measles, mumps & rubella antibodies among 5-10 years old children in north India

Gupta

Tripathy

Verma

et al. 2019

Indian Journal of Medical Research

View full text Add to dashboard Cite

Background & objectives: Globally, there is an effort to eliminate the measles and control rubella as these diseases lead to considerable morbidity and mortality especially among under-five children and are important public health problems. This study was aimed to estimate the seroprevalence of measles, mumps and rubella (MMR) antibodies among children of age 5-10 yr in Chandigarh, north India, to provide evidence on prevalent immunity levels. Methods: This cross-sectional study was conducted in Chandigarh, among 196 randomly selected healthy children (5-10 yr), who received either one or two doses of measles or MMR combination vaccine. Socio-economic background and immunization history were recorded. Blood sample (2 ml) was collected to estimate the MMR IgG antibody titres by using ELISA kits. Results: Protective seroprevalence of MMR antibodies was 40.8, 75.5 and 86.2 per cent, respectively. The geometric mean titres of MMR IgG antibodies in the study children were 11.3, 50.6 and 54.3 international units (IU)/ ml, respectively. The proportion of seroprotected children for measles was significantly higher among those who had received two or more doses (46.4%) of measles vaccine compared to those who had received single dose (35.6%) ( P <0.001). About 16 per cent of children had received single dose of MMR vaccine. Among these, 71.4 and 100 per cent were seroprotected against mumps and rubella, respectively. Interpretation & conclusions: A large proportion of children aged 5-10 yr lacked protective immunity against measles (60%); about one-fourth (15-25%) were susceptible to infection with mumps and rubella virus. Mumps vaccination may be considered to be included in National Immunization Schedule for children with periodic serosurveillance.

show abstract

“…The whole country will be covered in four phases in eighteen months. All kids matured between nine months and under 15 years will be given a solitary shot of MR inoculation regardless of their past measles/rubella immunization status or measles/rubella illness status 61,62,63 . There is question can India achieve this goal by 2020?…”

Section: Preventive Measures Of Rubella In India: Indianmentioning

confidence: 99%

Untitled

2019

IJPSR

View full text Add to dashboard Cite

Rubella is an eradicable illness on the grounds of immunization against it produces solid protection. The name rubella comes from the Latin language, and it means "little red". In olden times people thought that rubella was a variant of measles. German literature first described it as a separate disease, and hence it was also called "German Measles". People are the main reservoir of the infection. Before inoculation, rubella was endemic around the world, with plagues occurring every 6-9 years. Congenital rubella syndrome (CRS) acquires a very important place in rubella infection since it leads to a highly damaging effect on the health of newborns. It is transmitted to them by their mothers who have acquired this infection. Babies conceived every year with inborn rubella disorder is a disaster. Although, effective vaccination programs against rubella, especially in combination with immunization against measles has led to the eradication of this disease especially in developed countries like United States of America, still it is vital to recollect that having a powerful antibody does not ensure control of sicknessthe immunization must be appropriated to all who require it. This review focused on the history, mechanism of rubella infection, manifestation and preventive measures for rubella in India. Indian government has launched MR vaccination campaign targeting the children of 9-12 year age group. INTRODUCTION: Rubella is an infection that is spread through the air or by close contact in humans. Rubella virus (RV) belongs to the genus rubivirus. It belongs to the family Togaviridae. Rubella virus infection brings about various complications in a human-like maculopapular rash, second rate fever, lymphadenopathy, sore throat and general disquietude 1. Its genetic material consists of positive-stranded sense RNA 2 .

show abstract

2017 Measles-Rubella Vaccination Campaign in India

Cited by 7 publications

References 2 publications

Drivers and barriers for measles rubella vaccination campaign: A qualitative study

Drivers and barriers for measles rubella vaccination campaign: A qualitative study

Seroprevalence of measles, mumps & rubella antibodies among 5-10 years old children in north India

Untitled

Contact Info

Product

Resources

About